• Featured Product
  • KD/KO Validated

VRK2 Polyklonaler Antikörper

VRK2 Polyklonal Antikörper für WB, IHC, IP, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IHC, IP, ELISA

Konjugation

Unkonjugiert

Publikationen(4)

Kat-Nr. : 12946-1-AP

Synonyme

Vaccinia-related kinase 2, vaccinia related kinase 2, Serine/threonine-protein kinase VRK2, EC:2.7.11.1



Geprüfte Anwendungen

Erfolgreiche Detektion in WBHepG2-Zellen, BxPC-3-Zellen, humanes Lebergewebe, K-562-Zellen, Maus-Skelettmuskelgewebe, U2OS-Zellen
Erfolgreiche IPK-562-Zellen
Erfolgreiche Detektion in IHChumanes Magengewebe
Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:500-1:2000
Immunpräzipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunhistochemie (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

12946-1-AP bindet in WB, IHC, IP, ELISA VRK2 und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
In Publikationen genannte Reaktivitäthuman, Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen VRK2 fusion protein Ag4019
Vollständiger Name vaccinia related kinase 2
Berechnetes Molekulargewicht 508 aa, 58 kDa
Beobachtetes Molekulargewicht 50 kDa
GenBank-ZugangsnummerBC027854
Gene symbol VRK2
Gene ID (NCBI) 7444
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS with 0.02% sodium azide and 50% glycerol
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Vaccinia-related kinase 2 (VRK2) is a serine/threonine kinase that plays a significant role in various cellular processes, including cell survival, proliferation, and DNA damage response. The VRK2 gene is known to produce two main splice variants: VRK2A and VRK2B, with VRK2A being the predominant form in humans. VRK2 is involved in several key biological functions. It is known to enhance cell survival by acting as an anti-apoptotic factor, which is particularly crucial in cancer biology. The overexpression of VRK2 has been linked to increased drug sensitivity in cancer cells, suggesting that this kinase may play a role in therapeutic responses. Additionally, high levels of VRK2 protein have been associated with improved survival rates in specific subgroups of astrocytomas, a type of brain tumor. (PMID: 29872222; 37943248; 24079673)

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
WB protocol for VRK2 antibody 12946-1-APProtokoll herunterladen
IHC protocol for VRK2 antibody 12946-1-APProtokoll herunterladenl
IP protocol for VRK2 antibody 12946-1-APProtokoll herunterladen
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB

Oncogene

β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma.

Authors - Yanwei Lu
humanWB

Int J Biol Sci

VRK2 activates TNFα/NF-κB signaling by phosphorylating IKKβ in pancreatic cancer.

Authors - Jionghuang Chen
mouseWB

BMC Med

Reduced Vrk2 expression is associated with higher risk of depression in humans and mediates depressive-like behaviors in mice

Authors - Mei-Yu Yin
  • KO Validated
humanWB,IHC

Cell Rep

Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice

Authors - Xiao-Tong Lin
  • KD Validated